Gain Therapeutics Inc (GANX) institutional holders · $53.0M cap
Gain Therapeutics Inc 13F cache, top 1 holders by reported value. Each row is the filer's newest cached 13F for quarters ended 2026-06-30 or later, share lines summed, options excluded; value is the 13F-reported market value in US dollars. Filers whose newest cached 13F is older are omitted.
| Holder | Shares | Value | Report |
|---|---|---|---|
| STATE STREET CORP | 157,537 | $319.8K | 2026-06-30 |
GANX institutional holders FAQ
How many GANX 13F holders are listed on this page?
This page lists 1 cached Gain Therapeutics Inc (GANX) 13F holder. Holders: https://lician.com/institutional/ganx
Who is the largest GANX 13F holder by reported value?
The largest cached 13F holder by reported value on this page is STATE STREET CORP. Filer: https://lician.com/institutional/ganx/93751. Holders: https://lician.com/institutional/ganx
What value and shares did the largest GANX 13F holder report?
STATE STREET CORP, the largest cached 13F holder by reported value on this page, reported 157,537 shares and a value of $319.8K.
What is the latest GANX 13F report date on this page?
The latest cached 13F report date on this Gain Therapeutics Inc (GANX) holders table is Jun 30, 2026.
Where are GANX institutional holders listed?
Cached 13F holders for Gain Therapeutics Inc (GANX) are listed at https://lician.com/institutional/ganx. Filer directory: https://lician.com/holders
What is GANX's latest revenue?
Latest cached Gain Therapeutics Inc (GANX) revenue for Sep 30, 2023 was $55.2K. Statements: https://lician.com/financials/ganx
Not investment advice. Cached rows, not a live tape.